Kyle Jacoby

Company: Kanvas Bio

Job title: Vice President of Clinical Research

Seminars:

KAN-001, a Complex Consortium Live Biotherapeutic Product to Augment Cancer Therapy 11:30 am

From FMTs to LBPs: A reverse translational approach to creating an optimized and sustainable therapy to augment patients’ immune systems and response to cancer immune checkpoint therapy KAN-001 optimization and preclinical testing KAN-001 strains in patients: assessing existing KAN-001 strain-level clinical engraftment data de-risks developmentRead more

day: Conference Day One, Track Two, AM

Roundtable Discussion: Charting the Future of Microbiome-Driven Cancer Therapy: Integration, Innovation & Translation 12:00 pm

Reflect on key learnings from MaaT013 and KAN-001 to evaluate what defines a clinically successful and scalable microbiome-based oncology therapy Discuss the current barriers to integrating microbiome interventions with standard-of-care cancer therapies, particularly in immune-oncology and GI cancers Identify priority areas for biomarker development, patient stratification, and regulatory clarity to accelerate clinical translation Explore what’s…Read more

day: Conference Day One, Track Two, AM